{"id":"NCT02677805","sponsor":"Croma-Pharma GmbH","briefTitle":"Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II","officialTitle":"Randomized Double Blind Phase 3 Study to Assess the Efficacy and Safety of BoNT/A-DP in the Treatment of Glabellar Lines in Comparison With Placebo Followed by an Open Label Extension Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-03-30","primaryCompletion":"2016-09-15","completion":"2017-11-03","firstPosted":"2016-02-09","resultsPosted":"2025-03-19","lastUpdate":"2025-03-19"},"enrollment":251,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Glabellar Frown Lines"],"interventions":[{"type":"DRUG","name":"Botulinum Toxin A","otherNames":["BoNT/A-DP"]},{"type":"DRUG","name":"Placebo","otherNames":["sodium chloride 0.9 %"]},{"type":"DRUG","name":"Botulinum Toxin A - Open Label","otherNames":["BoNT/A-DP"]}],"arms":[{"label":"Botulinum toxin A","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Botulinum toxin A open label extension phase","type":"EXPERIMENTAL"}],"summary":"The aim of this study is to assess the efficacy and safety of BoNT/a-DP in the treatment of glabellar lines in comparison with placebo, including efficacy after repeat treatments and long term safety.","primaryOutcome":{"measure":"Facial Wrinkle Scale (FWS) Score of 0 or 1 and an Improvement of â‰¥ 2 Points in FWS Score (at Maximum Frown) at Week 4 Visit Relative to Baseline, Based on Both the Investigators' and the Subjects' In-clinic Assessments","timeFrame":"Week 4","effectByArm":[{"arm":"Botulinum Toxin A","deltaMin":78,"sd":null},{"arm":"Placebo","deltaMin":1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":18},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["38470985"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":160},"commonTop":["Upper respiratory tract infection","Headache","Urinary tract infection"]}}